Skip to main content
RKLBFYI

Intelligence Hub

Market analytics and operational performance indicators

Last Updated: 17 minutes ago
Back to Filings
FORM 4
AI

Insider Trading - June 14, 2024

Filed June 14, 2024
·
Period ending June 12, 2024
·
0000950170-24-073941

Director Griffin acquired 42,353 RSUs ($0) as compensation.

Brief

Michael D. Griffin, a Director at Rocket Lab USA, acquired 42,353 shares of common stock via restricted stock units (RSUs) on June 12, 2024. This grant under the Non-Employee Director Compensation Policy increases his direct holdings to 81,799 shares. The transaction is a bullish signal, reflecting equity-based compensation that aligns insider interests with shareholders.

Detailed Brief

On June 12, 2024, Michael D. Griffin, a Director of Rocket Lab USA, Inc. (RKLB), was granted 42,353 restricted stock units (RSUs) of common stock at $0.00 per share, as reported in the Form 4 filed on June 14, 2024. These RSUs vest in full on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Stockholders, per the company's Amended and Restated Non-Employee Director Compensation Policy. Post-transaction, Griffin directly beneficially owns 81,799 shares. No derivative transactions were reported, and the form does not indicate a Rule 10b5-1 plan. This appears to be a routine initial or annual director compensation grant, with no prior trading pattern detailed in the filing. The timing follows Q1 2024 earnings (May 7) and amid ongoing Neutron rocket developments, but lacks specific catalysts tied to the grant.

Key Telemetry

  • Acquired 42,353 RSUs (~52% increase in direct holdings to 81,799 shares)
  • Standard non-employee director compensation; vests in ~1 year or at next AGM
  • Post-Q1 earnings timing; no 10b5-1 plan noted
  • Bullish alignment signal, routine equity grant near recent price lows (~$4.50/share on 6/12)

Impact Vector

This RSU grant signals moderate bullish confidence, as it substantially increases the director's equity stake and aligns interests with shareholders without any selling activity. Routine compensation grants like this are positive but not as strong as discretionary purchases.

Search
Search across missions, customers, news, and SEC filings